4D-710 in Adult Patients With Cystic Fibrosis
Trial details
- Registry ID
- NCT05248230
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| 4D-710 in Adult Patients With Cystic FibrosisNCT05248230 | 4D Molecular Therapeutics | Phase 2 | Recruiting | 2027-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |